153 related articles for article (PubMed ID: 31702501)
1. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
[TBL] [Abstract][Full Text] [Related]
2. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
Uddin R; Sufian M
PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
[TBL] [Abstract][Full Text] [Related]
3. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
[TBL] [Abstract][Full Text] [Related]
4. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
Chand Y; Singh S
Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
[TBL] [Abstract][Full Text] [Related]
5. Genomics driven approach for identification of novel therapeutic targets in Salmonella enterica.
Gawade P; Ghosh P
Gene; 2018 Aug; 668():211-220. PubMed ID: 29778427
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential drug targets by subtractive genome analysis of Bacillus anthracis A0248: An in silico approach.
Rahman A; Noore S; Hasan A; Ullah R; Rahman H; Hossain A; Ali Y; Islam S
Comput Biol Chem; 2014 Oct; 52():66-72. PubMed ID: 25254941
[TBL] [Abstract][Full Text] [Related]
7. Gene interaction network studies to decipher the multi-drug resistance mechanism in Salmonella enterica serovar Typhi CT18 reveal potential drug targets.
Debroy R; Miryala SK; Naha A; Anbarasu A; Ramaiah S
Microb Pathog; 2020 Feb; 142():104096. PubMed ID: 32097747
[TBL] [Abstract][Full Text] [Related]
8. Paradigm Shift in Drug Re-purposing From Phenalenone to Phenaleno-Furanone to Combat Multi-Drug Resistant
Mujawar S; Gatherer D; Lahiri C
Front Cell Infect Microbiol; 2018; 8():402. PubMed ID: 30488026
[TBL] [Abstract][Full Text] [Related]
9. Prioritization of potential drug targets against P. aeruginosa by core proteomic analysis using computational subtractive genomics and Protein-Protein interaction network.
Uddin R; Jamil F
Comput Biol Chem; 2018 Jun; 74():115-122. PubMed ID: 29587180
[TBL] [Abstract][Full Text] [Related]
10. A Combination of Linalool, Vitamin C, and Copper Synergistically Triggers Reactive Oxygen Species and DNA Damage and Inhibits
Ghosh T; Srivastava SK; Gaurav A; Kumar A; Kumar P; Yadav AS; Pathania R; Navani NK
Appl Environ Microbiol; 2019 Feb; 85(4):. PubMed ID: 30552187
[TBL] [Abstract][Full Text] [Related]
11. Variable number of tandem repeats in Salmonella enterica subsp. enterica for typing purposes.
Ramisse V; Houssu P; Hernandez E; Denoeud F; Hilaire V; Lisanti O; Ramisse F; Cavallo JD; Vergnaud G
J Clin Microbiol; 2004 Dec; 42(12):5722-30. PubMed ID: 15583305
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel therapeutic target and epitopes through proteome mining from essential hypothetical proteins in Salmonella strains: An In silico approach towards antivirulence therapy and vaccine development.
Sah PP; Bhattacharya S; Banerjee A; Ray S
Infect Genet Evol; 2020 Sep; 83():104315. PubMed ID: 32276082
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18.
Deng W; Liou SR; Plunkett G; Mayhew GF; Rose DJ; Burland V; Kodoyianni V; Schwartz DC; Blattner FR
J Bacteriol; 2003 Apr; 185(7):2330-7. PubMed ID: 12644504
[TBL] [Abstract][Full Text] [Related]
14. Comparative genomics study for identification of putative drug targets in Salmonella typhi Ty2.
Batool N; Waqar M; Batool S
Gene; 2016 Jan; 576(1 Pt 3):544-59. PubMed ID: 26555890
[TBL] [Abstract][Full Text] [Related]
15. Novel antimicrobial peptides with promising activity against multidrug resistant Salmonella enterica serovar Choleraesuis and its stress response mechanism.
Tsai WC; Zhuang ZJ; Lin CY; Chen WJ
J Appl Microbiol; 2016 Oct; 121(4):952-65. PubMed ID: 27280957
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Salmonella enterica subsp. enterica serovar 4,[5],12:i:- clones isolated from human and other sources in Switzerland between 2007 and 2011.
Gallati C; Stephan R; Hächler H; Malorny B; Schroeter A; Nüesch-Inderbinen M
Foodborne Pathog Dis; 2013 Jun; 10(6):549-54. PubMed ID: 23614800
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K
Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
[TBL] [Abstract][Full Text] [Related]
19. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K; Khan W; Azam SS; Wadood A
Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated from patients in Japan.
Hirose K; Tamura K; Sagara H; Watanabe H
Antimicrob Agents Chemother; 2001 Mar; 45(3):956-8. PubMed ID: 11181390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
